Big health care’s big test

CITY

Accenture’s CEO has quietly built the consulting company into a go-to expert on mastering AI. But can she save her industry from being replaced by robots?

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

In 2005, BP was No. 2 on the Fortune Global 500 and was carving out a role as an early adapter to the green energy transition. Now there’s speculation about whether the struggling $85 billion supermajor will survive as a freestanding company.

Companies in the news and how they were assessed

CITY